Fri, June 21, 2019
Thu, June 20, 2019
Wed, June 19, 2019
Tue, June 18, 2019
Mon, June 17, 2019
Fri, June 14, 2019
Thu, June 13, 2019

Matthew Luchini Maintained (BLUE) at Buy with Decreased Target to $163 on, Jun 17th, 2019

Matthew Luchini of BMO Capital, Maintained "bluebird bio, Inc." (BLUE) at Buy with Decreased Target from $191 to $163 on, Jun 17th, 2019.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Tuesday, March 5th, 2019


This is the rating of the analyst that currently disagrees with Matthew


  • Yaron Werber of "Cowen & Co." Initiated at Buy on, Tuesday, February 26th, 2019